Related Experiment Video
Updated: Jun 25, 2026

Murine Model of Femoral Artery Wire Injury with Implantation of a Perivascular Drug Delivery Patch
Published on: February 10, 2015
Deferoxamine Intradermal Delivery Patch for Treatment of a Beta-Thalassemia Wound
David Perrault1, Arhana Chattopadhyay1, Dharshan Sivaraj1,2
1From the Division of Plastic and Reconstructive Medicine, Stanford University School of Medicine, Stanford University, Stanford, CA.
Mini-Abstract:
In this study, we present the first-in-human use of topical deferoxamine (DFO) in the treatment of a beta-thalassemia wound. We elected to use DFO on a patient that suffered from a chronic nonhealing wound in the setting of beta-thalassemia. Despite approximately 55 weeks of marginal improvement in healing, this patient's wound healed completely after 21 weeks of treatment with DFO. We believe that DFO has the potential to accelerate healing in beta-thalassemia wounds through iron chelation.
More Related Videos
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
07:41Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
Published on: July 12, 2024
Related Concept Videos
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Transdermal Drug Delivery Systems